SKU(재고 관리 코드):PAF709Hu01
Polyclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4)
Polyclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4)
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
Product No.
PAF709Hu01
Organism Species
Homo sapiens (Human).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPF709Hu01-Recombinant Peptidyl Arginine Deiminase Type IV (PADI4)
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
0.5mg/ml
Organism Species More
n/a
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against PADI4. It has been selected for its ability to recognize PADI4 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Magazine |
Citations |
Arthritis Res Ther. |
Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility Pubmed:Pmc4229860 |
Journal of Molecular Cell Biology |
Peptidylarginine deiminase 4 concentration, but not polymorphisms, is associated with ICU mortality in septic shock patients Pubmed:30044533 |
Journal of Inflammation Research |
Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery Pubmed: 31213874 |
Revista da Associacao Medica Brasileira |
Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury |
Catalog No. |
Related products for research use of Homo sapiens (Human) Organism species |
Applications (RESEARCH USE ONLY!) |
RPF709Hu01 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
PAF709Hu01 |
Polyclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) |
WB; IHC; ICC; IP. |
MAF709Hu21 |
Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) |
WB |
MAF709Hu22 |
Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) |
WB; IHC; ICC; IP. |
MAF709Hu23 |
Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) |
WB; IHC; ICC; IP. |
MAF709Hu24 |
Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) |
WB; IHC; ICC; IP. |
SEF709Hu |
Enzyme-linked immunosorbent assay for Antigen Detection. |
|
LMF709Hu |
Magnetic Luminex Assay Kit for Peptidyl Arginine Deiminase Type IV (PADI4) ,etc. |
Magnetic Luminex Assay for Antigen Detection. |